Bicara Therapeutics BCAX Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bicara Therapeutics's change in other assets?
- Bicara Therapeutics (BCAX) reported change in other assets of -$2.09M in Q1 2026.
- How has Bicara Therapeutics's change in other assets changed year-over-year?
- Bicara Therapeutics's change in other assets increased by 49.2% year-over-year, from -$4.12M to -$2.09M.
- What does change in other assets mean?
- Change in miscellaneous assets affecting operating cash flow.